Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 19, 2006
0Patent Application Number
103667090
Date Filed
February 14, 2003
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides humanized, chimeric and human anti-CD20 antibodies and CD 20 antibody fusion proteins that bind to a human B cell marker, referred to as CD20, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies and autoimmune diseases, and methods of treatment and diagnosis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
